Rainbow City Medicaid providers charged $725,783 for services categorized under Pathology and Laboratory Procedures in 2024, data from the U.S. Department of Health and Human Services Medicaid Provider Spending database show. This figure represents a 562.3% rise from 2023, when claims for the same service type totaled $109,579.
Medicaid is a public health insurance program administered by states with both federal and state funding, covering low-income individuals and families, as well as seniors, children, and people with disabilities. It is one of the largest segments of the U.S. health care system. More detail is available at the Commonwealth Fund.
Because Medicaid is taxpayer-funded, variations in local billing illustrate how health care funds are distributed throughout a community.
The “Pathology and Laboratory Procedures” category groups specific Medicaid-covered services by the type of care delivered, based on uniform HCPCS and CPT code classifications. Each billing code in this analysis was assigned to a single service group using defined code ranges and prefixes, which helped group related services without overlap and maintained accurate rankings over time.
Spending on Medicaid increased in several service groups, with Pathology and Laboratory Procedures ranking second in Rainbow City by total Medicaid payments in 2024.
On a statewide level in Alabama, Pathology and Laboratory Procedures ranked third in total Medicaid payments for 2024.
Over the five years up to 2024, Rainbow City’s Medicaid payments for Pathology and Laboratory Procedures rose by $698,169, an increase of 2528.3%. Periods of significant spending acceleration were observed, notably in 2021 and 2022 with large year-over-year gains.
Although the spending was spread across Rainbow City, most Medicaid payments for this category were focused in a small number of ZIP codes. In 2024, ZIP code 35906 accounted for the entire $725,783 total in Medicaid payments tied to Pathology and Laboratory Procedures, representing 100% of that category’s payments in the city for the year.
Payments within the Pathology and Laboratory Procedures category were also concentrated around a select number of billing codes.
For perspective, Medicaid payments connected to Pathology and Laboratory Procedures in Rainbow City jumped 562.3% from 2023 to 2024, while payments across all Medicaid claim categories citywide grew by 137% during the same period.
Data from the Centers for Medicare & Medicaid Services indicates that total federal and state Medicaid expenditures were about $871.7 billion in fiscal year 2023, representing roughly 18% of all U.S. health expenditures. This is a substantial increase compared with the approximate $613.5 billion spent in 2019, prior to the COVID-19 pandemic.
This change equals a growth rate of approximately 40% within a few years, attributed mainly to expanded enrollment and higher utilization during and after the pandemic.
Recent federal budget measures enacted during the Trump administration proposed considerable cuts to federal Medicaid funding and structural changes to the program. The “One Big Beautiful Bill Act,” which became law in 2025, is anticipated to reduce federal Medicaid spending by over $1 trillion in the next 10 years and includes policies such as work requirements and greater cost-sharing, which may limit coverage and resources for some recipients. These policies are likely to shift more costs to states and slow the expansion of federal Medicaid support, while the program continues to cover many Americans.
| Year | Total Medicaid Payments | % Change From Previous Year |
|---|---|---|
| 2020 | $27,613 | -35.5% |
| 2021 | $72,159 | 161.3% |
| 2022 | $146,295 | 102.7% |
| 2023 | $109,579 | -25.1% |
| 2024 | $725,783 | 562.3% |
| Rank | Category | Medicaid Payments | Share of City Total |
|---|---|---|---|
| 1 | National Codes Established for State Medicaid Agencies | $879,161 | 35.1% |
| 2 | Pathology and Laboratory Procedures | $725,783 | 29% |
| 3 | Evaluation and Management | $559,790 | 22.4% |
| 4 | Medicine Services and Procedures | $157,065 | 6.3% |
| 5 | Orthotic Procedures and services | $117,933 | 4.7% |
| 6 | Durable Medical Equipment | $53,881 | 2.2% |
| 7 | Dental Services | $7,670 | 0.3% |
| 8 | Medical And Surgical Supplies | $328 | <0.1% |
| 9 | Surgery | $0 | <0.1% |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87633 | Resp virus 12-25 targets | $254,717 | 24 |
| 87798 | Detect agent nos dna amp | $207,641 | 15 |
| 87636 | Sarscov2 & inf a&b amp prb | $112,017 | 16 |
| 87581 | M.pneumon dna amp probe | $33,448 | 23 |
| 87811 | Sars-cov-2 covid19 w/optic | $26,678 | 31 |
| 87804 | Influenza assay w/optic | $21,925 | 37 |
| 87880 | Strep a assay w/optic | $15,988 | 45 |
| 85025 | Complete cbc w/auto diff wbc | $15,228 | 51 |
| 87631 | Resp virus 3-5 targets | $9,691 | 1 |
| 87498 | Enterovirus probe&revrs trns | $5,522 | 7 |
| 87640 | Staph a dna amp probe | $5,503 | 7 |
| 86684 | Hemophilus influenza antibdy | $4,529 | 7 |
| 87634 | Rsv dna/rna amp probe | $4,186 | 5 |
| 87635 | Sars-cov-2 covid-19 amp prb | $3,924 | 6 |
| 86615 | Bordetella antibody | $3,538 | 7 |
| 80305 | Drug test prsmv dir opt obs | $1,147 | 9 |
| 81002 | Urinalysis nonauto w/o scope | $51 | 1 |
| 85018 | Hemoglobin | $42 | 1 |
| 80307 | Drug test prsmv chem anlyzr | $0 | 10 |
Note: HCPCS codes are shown for context within the category. Category totals and rankings in this article are based on standardized service groupings rather than individual billing codes.
Information in this article was obtained from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The source data can be found here.
